US Patent 11747351 Assays to monitor bleeding disorders
Patent 11747351 was granted and assigned to Bioverativ on September, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 7 Sep, 2023
Golden AI
Edits made to:
Infobox (+25 properties)
Article (+239 characters)
US Patent 11747351 Assays to monitor bleeding disorders
Article
The present invention provides methods of dosing Factor VIII or Factor IX chimeric and hybrid polypeptides. The present invention further provides high-sensitivity methods of quantifying an amount of activated FIX protein in a test sample.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
11747351
Patent Inventor Names
Buyue Yang
Glenn Pierce
Haiyan Jiang
Jurg Sommer
Xin Zhang
Date of Patent
September 5, 2023
Patent Application Number
16848445
Date Filed
April 14, 2020
Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11747351 Assays to monitor bleeding disorders
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.